Revolutionizing Liver Disease Treatment: Ochre Bio and Boehringer Ingelheim Join Forces for Groundbreaking Regenerative Solutions
Ochre Bio announces partnership with Boehringer Ingelheim to accelerate discovery of novel targets for liver diseases Partnership highlights human-centric approach to drug discovery Ochre Bio, a leader in chronic liver disease research and development, has entered into a strategic partnership with Boehringer Ingelheim to leverage its unique human-centric discovery capabilities. By combining deep phenotyping, RNA…